C.R. Bard, Inc. (NYSE:BCR)

CAPS Rating: 4 out of 5

The Company is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.


Player Avatar DrGoldin (99.68) Submitted: 1/14/2013 12:24:36 AM : Outperform Start Price: $100.95 BCR Score: +16.15

No pitch for C.R. Bard since 2011? They're profitable. They're CONSISTENTLY profitable. They're in a sector that can only improve. The price is reasonable. What's not to like?

Featured Broker Partners